One of the outpatient rehabilitation alternatives for individuals in Exton who are struggling with opioid abuse and addiction is opioid maintenance therapy. Licensed centers and doctors are authorized to give certain medications to opioid dependent people, many that are opioid-based also and are habit forming. In low amounts the user doesn't experience being high but also doesn't have intense cravings and is not experiencing opioid withdrawal. Methadone is the first drug tried for this reason, but there are alternative options currently to choose from.
Methadone is an opiate and can be taken at an out-patient clinic licensed to dispense the drug, which is taken daily in liquid or pill form. The cost of the med is around $150 monthly. Buprenorphine is also an opiate based drug, and is in pill form often taken every other day. But unlike Methadone that is only be given in well-regulated clinics, Buprenorphine can be and is prescribed and administered in doctor's offices. The cost monthly of buprenorphine is around three hundred dollars per month for the generic of the medication. There is also a type of buprenorphine that contains the ingredient naloxone, that is a med which reverses the effects of opiates. An individual consuming this version of the drug, AKA Suboxone, would find it more difficult to get high from opioids if they relapsed while taking the drug. It is also taken on a daily basis, and is priced about $450 monthly. Naltrexone is an additional medication used in opioid maintenance therapy, but unlike the other medications mentioned here it is an opiate blocker and isn't an opiate. A person has the choice to take this medication as a monthly injection, which is called Vivitrol. As an opioid blocker, it prevents someone from getting high from opioids, and therefore lowers the risk associated with relapse. This daily shot costs anywhere from $1000 to $1200 a month.
There are 1 Alcohol and Drug Rehabilitation Centers offering this service in Exton, PA
For All Alcohol and Drug Rehabilitation Centers In Exton, Click Here.